News
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...
Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty care platform with the acquisition of Solaris Health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results